|
|
| Quarterly Results |
|
| Aurobindo Pharma Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : K Ragunathan | | Home : Indian Private | Book Value: 318.5455537 | | BSE Code : 524804 | Market Cap: 67608.53 | | NSE Code : AUROPHARMA | P / E : 34.38 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 2663.87 | 2648.41 | 2363.53 | 2371.73 | | Other Income | 331.13 | 103.17 | 112.83 | 279.96 | | Total Income | 3023.16 | 2771.93 | 2503.65 | 2686.19 | | Total Expenditure | 2210.34 | 2123.58 | 1968.44 | 1830.29 | | Operating Profit | 812.82 | 648.35 | 535.21 | 855.90 | | Interest | 61.25 | 36.69 | 31.59 | 31.77 | | Gross Profit | 751.57 | 611.66 | 503.62 | 824.13 | | Depreciation | 64.35 | 65.79 | 59.63 | 66.68 | | Tax | 136.95 | 137.17 | 116.30 | 115.07 | | Deferred Tax | -73.51 | -7.04 | -8.26 | -2.42 | | Reported Profit After Tax | 623.78 | 415.74 | 335.95 | 644.80 |
|
|
|
|
|